Novo Nordisk
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.About NVO
Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments.
NVO Key Statistics
NVO News
Key Points Eli Lilly said its experimental pill outperformed Novo Nordisk's own oral drug in the first head-to-head study comparing the two medicines in patient...
Berenberg upgraded Novo Nordisk (NVO) to Buy from Hold with a price target of DKK 425, down from DKK 610. The firm says Novo is now its preferred obesity play....
The U.S. FDA has issued separate warning letters to Eli Lilly (NYSE:LLY) and Novo Nordisk (NVO) regarding claims made about their obesity drugs in an Oprah Winf...
Analyst ratings
56%
of 32 ratingsMore NVO News
Zinger Key Points Since June 2024, Novo Nordisk has lost about 60% of its value. But there is a chance that a reversal may be taking place. If buyers overpower...
The FDA posted a warning letter sent to Novo Nordisk (NVO) over a weight loss video the agency deems “false or misleading.” The letter states, “The video misbra...
The agency’s letter took issue with the claims made in Hims’ marketing materials. Hims & Hers fell by more than 5% after the US Food and Drug Administration po...
Novo Nordisk A/S NVO reportedly said on Tuesday that it intends to seek US regulatory approval for a high-dose version of its weight-loss injection Wegovy (sema...
Danish drugmaker Novo Nordisk (NVO) said its new survey in the U.S. shows that its weight loss drug, Wegovy, helps to douse “food noise” among 46% of users who...
Novo Nordisk (NVO) presented data from a sub-analysis of the phase 3 REDEFINE 1 trial at the European Association for the Study of Diabetes congress 2025 from 1...
Novo Nordisk (NVO) Chief Scientific Officer Martin Holst Lange said on Tuesday at the European Association for the Study of Diabetes conference in Vienna that t...